Mylan Laboratories Ltd.
|BSE: 524794||Sector: Health care|
|NSE: MATRIXLABS||ISIN Code: INE604D01023|
|BSE 05:30 | 01 Jan||Stock Is Not Traded.|
|NSE 05:30 | 01 Jan||Stock Is Not Traded.|
Mylan Laboratories Ltd. (MATRIXLABS) - Latest News & Headlines
2.34 pm | 29 Dec 2017 | Press Trust of India
Biocon said biosimilar trastuzumab will be manufactured by it and supplied to Libbs for commercialisation in Brazil
10.13 pm | 9 Sep 2017 | Business Standard
BS ReporterHyderabad, 6 September: American generics drug major Mylan is looking for a buyer for its formulations manufacturing facility in Vizag Pha...
4.49 pm | 27 Jul 2017 | Business Standard
BS ReporterHyderabad, 27 July: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N V, today announced the launch of Velpatasvir 100 mg/Sofo...